T5224, RSPO2 and AZD5363 are novel drugs against functional pituitary adenoma

We tested whether the drugs T5224, RSPO2, and AZD5363 exert therapeutic effects against functioning pituitary adenoma (FPA). We analysed the gene expression profiles of four FPA mRNA microarray datasets (GSE2175, GSE26966, GSE36314, and GSE37153) from the Gene Expression Omnibus database and identif...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Sheng, Wu, Bo, Li, Jiahui, Wang, Xinhui, Jiang, Shanshan, Hu, Fangfei, Dou, Gaojing, Zhang, Yuan, Sheng, Chunjia, Zhao, Gang, Li, Yunqian, Chen, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834428/
https://www.ncbi.nlm.nih.gov/pubmed/31655798
http://dx.doi.org/10.18632/aging.102372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834428/
https://www.ncbi.nlm.nih.gov/pubmed/31655798
http://dx.doi.org/10.18632/aging.102372

Ejemplares similares